BHF UMOD Study - COVID-19 Update
During the current COVID-19 pandemic your safety is our main concern. Please be assured we will comply with all Government, Health Research Authority and NHS Guidelines on clinical research studies during these difficult times.
High blood pressure (hypertension) is common and often difficult to treat. Currently the initial choice of medication is based upon a person’s age and ethnic background however only around half of patients given an individual drug will respond.
This study aims to establish if people with different genetic make-up (genotype) respond better or worse to the blood pressure lowering drug torasemide. If people with different genetic make-up respond differently to drugs then in the future we may be better able to choose the best drug for each person.
For all information, please read the information sheet. You can also call us on
Registration for the BHF-UMOD Study has now closed.
Thank you for your interest in the study.